The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
The link between fungi and severe asthma: a summary of the evidence
Open accessAbstract
There is current evidence to demonstrate a close association between fungal sensitisation and asthma severity. Whether such an association is causal remains to be confirmed, but this is explored by means of a detailed literature review. There is evidence from two randomised controlled trials that, in the example of allergic bronchopulmonary aspergillosis (ABPA), treatment with systemic antifungal therapy can offer a therapeutic benefit to ∼60% of patients. ABPA is only diagnosed if a combination of clinical and immunological criteria is achieved. It is not known whether such cases are a discrete clinical entity or part of a spectrum of the pulmonary allergic response to fungi or fungal products. This paper describes the epidemiological evidence that associates severity of asthma with fungi and discusses possible pathogenetic mechanisms. Many airborne fungi are involved, including species of Alternaria , Aspergillus , Cladosporium and Penicillium , and exposure may be indoors, outdoors or both. The potential for a therapeutic role of antifungal agents for patients with severe asthma and fungal sensitisation is also explored. Not only are many patients with severe asthma desperately disabled by their disease, but, in the UK alone, asthma accounts for 1,500 deaths per yr. The healthcare costs of these patients are enormous and any treatment option merits close scrutiny. Within this report, the case for the consideration of a new term related to this association is put forward. The current authors propose the term “severe asthma with fungal sensitisation”. However, it is recognised that enhanced and precise definition of fungal sensitisation will require improvements in diagnostic testing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is estimated that 3% of adult asthmatics will have SAFS and this might account for more than 6.5 million cases globally [145].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [145]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Fungal infections can further complicate chronic conditions and nonfungal infections, reported in patients with asthma [12], cirrhosis [13], chronic obstructive pulmonary disease (COPD) [14], diabetes [15, 16], cystic fibrosis (CF) [17, 18], tuberculosis [19], and influenza [20, 21].”
From Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018 (2022) · cites this paper as [12]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The echinocandins caspofungin and micafungin have been used as primary therapy in noncomparative studies of IA, with response rates ranging from 33% to 57% for caspofungin (687–690) and 45% to 71% for micafungin (54, 479, 691).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [54]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to Allergens
Burrows, B., Martinez, F. D., Halonen, M., Barbee, R. A., & Cline, M. G. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200502 · Cited by 1,659
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
Broncho-pulmonary Aspergillosis : A Review and a Report of Eight New Cases
Hinson, K. F. W., Moon, A. J., & Plummer, N. S. (1952) · Thorax · doi:10.1136/thx.7.4.317 · Cited by 790
Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790
Self-citationThe germless theory of allergic disease: revisiting the hygiene hypothesis
Wills-Karp, M., Santeliz, J., & Karp, C. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095579 · Cited by 788
O'Hollaren, M. T., Yunginger, J. W., Offord, K. P., Somers, M. J., O'Connell, E. J., Ballard, D. J., & Sachs, M. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240602 · Cited by 694
A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis
Stevens, D. A., Schwartz, H. J., Lee, J. Y., Moskovitz, B. L., Jerome, D. C., Catanzaro, A., Bamberger, D. M., Weinmann, A. J., Tuazon, C. U., Judson, M. A., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003163421102 · Cited by 533
Zureik, M., Neukirch, C., Leynaert, B., Liard, R., Bousquet, J., & Neukirch, F. (2002) · BMJ · doi:10.1136/bmj.325.7361.411 · Cited by 488
Kitler, M. E. (2005) · International Journal of Pharmaceutical Medicine · doi:10.2165/00124363-200519040-00007 · Cited by 480
Redecke, V., Häcker, H., Datta, S. K., Fermin, A., Pitha, P. M., Broide, D. H., & Raz, E. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2739 · Cited by 448
Research works printed but not linked: 22
- Ainsworth GC. Spores as allergens: a problem of sensitization. In: An Introduction to Medical and Veterinary Mycology. Cambridge, Cambridge University Press, 1986
- Floyer J. A treatise of the asthma. 1698; pp. 74
- 1924, Proc Roy Soc Med, 17, 19
- 1925, Ztschr Immunitatsforsch, 44, 1
- 1928, Verhandl Deutsch Gesellsch Inn Med, 40, 204
- 1930, MJ & Rec, 132, 382
- 1936, J Allergy, 7, 454
- 1999, Eur Respir J, 13, 1198
- 1997, Eur Respir Rev, 40, 8
- 1991, J Lab Clin Med, 117, 138
- 2004, Am J Respir Crit Care Med, 169, A309
- 1990, Can J Public Health, 81, 226
- 10.1111/j.1365-2222.1997.tb01206.x · doi:10.1111/j.1365-2222.1997.tb01206.x
- 1993, J Occup Med, 35, 1231
- 1991, Br J Ind Med, 48, 279
- 1989, Lancet, 1, 859
- 1993, Allergol Immunopathol (Madr), 21, 84
- 2003, Eur Respir J, 2, 317
- 10.1080/080352599750030112 · DOI
- 2003, Nihon Kokyuki Gakkai Zasshi, 41, 233
- 2000, N Engl J Med, 11, 756
- 2004, Cochrane Database Syst Rev, 3, CD001108
Cited by
Hidden Killers: Human Fungal Infections
Brown, G. D., Denning, D. W., Gow, N. A. R., Levitz, S. M., Netea, M. G., & White, T. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004404 · Cited by 4,284
Self-citationGlobal and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“Asthmatic patients with severe disease (British Thoracic Society step 4 or worse ) who have evidence of sensitized to one or more fungi, by skin prick test or RAST test but do not meet the diagnostic criteria for ABPA (total IgE < 1000 IU/mL) are classified as patients with Severe Asthma with Fung l Sensitization (SAF…”
BackgroundSelf-citationAspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Agarwal, R., Chakrabarti, A., Shah, A., Gupta, D., Meis, J. F., Guleria, R., Moss, R., Denning, D. W., & ABPA complicating asthma ISHAM working group (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12141 · Cited by 896
Self-citationBartemes, K. R., Iijima, K., Kobayashi, T., Kephart, G. M., McKenzie, A. N., & Kita, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102832 · Cited by 549
“alternata, has been established clinically and epidemiologically (27, 28).”
Background
Metadata
- Authors
- Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M.
- Affiliations
- University of Manchester (GB)
- University of Michigan (US)
- Corresponding author
- Denning, D. W.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2006-03
- Volume
- 27
- Issue
- 3
- Pages
- 615-626
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2147711737
- Cited by
- 824
- References
- 130
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 29 · 2023: 37 · 2022: 33 · 2021: 49 · 2020: 58 · 2019: 47 · 2018: 46 · 2017: 59 · 2016: 58 · 2015: 54 · 2014: 48 · 2013: 47 · 2012: 48
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Respiratory Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Occupational exposure and asthma
- Keywords
- severe asthma, allergic bronchopulmonary aspergillosis, antifungal therapy, airborne fungi, Aspergillus, Alternaria, Cladosporium, Penicillium, asthma severity, pathogenesis, diagnostic criteria
- MeSH terms
- Asthma, Humans, Mycoses, Severity of Illness Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The link between fungi and severe asthma: a summary of the evidence. https://app.cochat.ai/papers/10.1183/09031936.06.00074705
- The paper
- Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M. (2006). The link between fungi and severe asthma: a summary of the evidence. European Respiratory Journal. https://doi.org/10.1183/09031936.06.00074705
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.